Shivam Baghel

Shivam Baghel

BBA Finance | Christ University’25 | Aspiring Investment Banking Analyst | Financial Modeling & Valuation

Bengaluru, India
View LinkedIn
4roles
3skills
2education
8credentials

About

BBA Finance graduate from Christ University, Bangalore (Cum Laude, 2025) with hands-on experience in financial modeling, valuation, and deal-oriented business development. At Mygate, I worked on high-value client deals involving pricing analysis, revenue modeling, and contract structuring — generating ₹12L+ in cumulative revenue. I've also interned as a Financial Analyst and Stock Market Analyst, building models, conducting equity research, and supporting investment decisions. I'm actively targeting Investment Banking Analyst roles where I can contribute my analytical and client-facing skills in a deal-driven environment.

Experience

Investment Banking Analyst Intern

ProCapitas

4 mos

• Built valuation models across 3+ mandates — DCF (bear/base/bull scenarios), comparable company analysis, precedent transactions, and 52-week trading range — to construct Football Field valuation summaries. •Applied IRR, NPV, and WACC frameworks across transaction analyses to evaluate investment theses under multiple market scenarios. •Conducted sensitivity analysis on discount rates, exit multiples, and terminal growth rates to support deal team recommendations.

Business Consultant

Mygate

10 mos · Bengaluru, Karnataka, India

• Analyzed pricing structures, unit economics, and margin impact across 50+ client accounts to support commercial deal structuring and profitability decisions. • Developed revenue forecasting models tracking pipeline cash-flow visibility; drove INR 12,00,000+ in ARR through structured pricing negotiations and deal closure. • Coordinated with legal, finance, and operations on client onboarding — gaining working exposure to compliance workflows, KYC requirements, and internal controls.

Stock Market Management Intern

Acuevers

2 mos · New Delhi, Delhi, India

• Conducted equity research and financial statement analysis on listed companies, contributing to ₹4,00,000 portfolio value increase • Evaluated valuation metrics and market trends to support investment decisions; reduced portfolio risk by 15% through diversification

Financial Analyst Intern

Saurabh Varshney & Associates

3 mos · Mathura, Uttar Pradesh, India

• Built DCF, comps, and ratio-based valuation models for 5+ corporate clients; improved deal evaluation efficiency by 20%. • Analyzed INR 50+ Cr in financial statements across 3 M&A mandates; performed bull/base/bear scenario analysis for M&A advisory and investment banking mandates.

Education

Christ University, Bangalore

Bachelor of Business Administration - BBA, Finance and International Business

Aug 2022 - May 2025

Gained hands-on experience in financial research and investment analysis, applying theoretical knowledge to practical scenarios. Participated in MUN, honing negotiation, diplomacy, and public speaking skills through global discussions. Conducted research on AI & ML in financial decision-making, developing predictive models and analyzing their impact on market trends and risk management.

Modern Academy International

High School Diploma

Apr 2018 - Mar 2022

I balanced academics with football and debate competitions during school, honing teamwork, leadership, and public speaking skills. Winning awards in both sports and academics fueled my drive for excellence, shaping a well-rounded foundation for future challenges.

Skills

Financial ModellingDCFValuation

Projects

Equity Valuation — Eureka Forbes Limited (NSE: EUREKAFORB)

Conducted a comprehensive equity valuation of Eureka Forbes Limited (NSE: EUREKAFORB), a leading consumer durables company, using four methodologies to arrive at a Football Field valuation summary. Methodologies used: 1. DCF Analysis — Built a 5-year forecast model (FY26–FY30) with Bull/Base/Bear scenarios. Derived WACC of 13.06% using CAPM and peer beta analysis across 6 comparable companies. Base case intrinsic value: ₹218/share 2. Comparable Company Analysis — Benchmarked against 6 peers (Havells, Crompton Greaves, Whirlpool India) using EV/Revenue, EV/EBITDA, and P/E multiples. Implied range: ₹405–465 3. 52-Week Range Analysis — Assessed historical trading range (₹403–668) to gauge market sentiment 4. Analyst Consensus — Incorporated sell-side targets (₹586–750) to compare intrinsic vs. market view Conclusion: Stock trading at ₹448 — fairly valued on comps but ~51% overvalued on DCF basis. Recommendation: HOLD / Speculative Buy, contingent on revenue acceleration and margin expansion. Tools: Microsoft Excel | Financial Statement Analysis (FY2022–FY2025)

Equity Valuation — Alkem Laboratories Limited (NSE: ALKEM)

Built a multi-scenario financial model and equity valuation for Alkem Laboratories (large-cap pharma, ₹1,16,000MM revenue), benchmarking against 10 peers including Dr. Reddy's, Lupin, and Zydus. • DCF (Bull/Base/Bear) — WACC of 9.66% via CAPM and peer beta unlevering. Intrinsic value: ₹4,471–₹6,101/share • Comps — EV/Revenue, EV/EBITDA, P/E across 10 pharma peers. Implied: ₹5,373–₹6,351 • Sensitivity table — stress-tested across discount rates (8–11%) and exit multiples (15x–35x) • Segmented revenue — bottom-up forecast for India, US, and Other Countries separately Conclusion: Fairly valued at ₹5,421. HOLD — upside contingent on India growth and margin recovery. Tools: Microsoft Excel

Volunteering

Volunteer

ASHA CHARITABLE TRUST

Apr 2023 · 1 mo

Volunteer

MRD Welfare Society

Sep 2018 - Nov 2018 · 3 mos